BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17804642)

  • 1. p53 RNA interactions: new clues in an old mystery.
    Riley KJ; Maher LJ
    RNA; 2007 Nov; 13(11):1825-33. PubMed ID: 17804642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling to p53: breaking the posttranslational modification code.
    Appella E; Anderson CW
    Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.
    Riley KJ; Cassiday LA; Kumar A; Maher LJ
    RNA; 2006 Apr; 12(4):620-30. PubMed ID: 16581806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-p53 interactions in vitro.
    Riley KJ; Ramirez-Alvarado M; Maher LJ
    Biochemistry; 2007 Mar; 46(9):2480-7. PubMed ID: 17288451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of p53-RNA interactions in cultured human cells.
    Riley KJ; James Maher L
    Biochem Biophys Res Commun; 2007 Nov; 363(2):381-7. PubMed ID: 17869221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.
    Yoshida Y; Izumi H; Torigoe T; Ishiguchi H; Yoshida T; Itoh H; Kohno K
    Oncogene; 2004 May; 23(25):4371-9. PubMed ID: 15064727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational modification of p53.
    Meek DW
    Semin Cancer Biol; 1994 Jun; 5(3):203-10. PubMed ID: 7948948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 searches on DNA by rotation-uncoupled sliding at C-terminal tails and restricted hopping of core domains.
    Terakawa T; Kenzaki H; Takada S
    J Am Chem Soc; 2012 Sep; 134(35):14555-62. PubMed ID: 22880817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of azurin and C-terminal domain of p53 is mediated by nucleic acids.
    Xu C; Zhao Y; Zhao B
    Arch Biochem Biophys; 2010 Nov; 503(2):223-9. PubMed ID: 20800053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the intrinsic aggregation potential of evolutionarily conserved segments in p53.
    Ghosh S; Ghosh D; Ranganathan S; Anoop A; P SK; Jha NN; Padinhateeri R; Maji SK
    Biochemistry; 2014 Sep; 53(38):5995-6010. PubMed ID: 25181279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex interactions of p53 with target DNA: we learn as we go.
    Kim E; Deppert W
    Biochem Cell Biol; 2003 Jun; 81(3):141-50. PubMed ID: 12897847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural aspects of the p53 protein in relation to gene evolution: a second look.
    Soussi T; May P
    J Mol Biol; 1996 Aug; 260(5):623-37. PubMed ID: 8709143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L; Meek DW
    Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.
    Kovachev PS; Banerjee D; Rangel LP; Eriksson J; Pedrote MM; Martins-Dinis MMDC; Edwards K; Cordeiro Y; Silva JL; Sanyal S
    J Biol Chem; 2017 Jun; 292(22):9345-9357. PubMed ID: 28420731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry.
    Abraham J; Kelly J; Thibault P; Benchimol S
    J Mol Biol; 2000 Jan; 295(4):853-64. PubMed ID: 10656795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer.
    Schumacher B; Mondry J; Thiel P; Weyand M; Ottmann C
    FEBS Lett; 2010 Apr; 584(8):1443-8. PubMed ID: 20206173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro.
    Cuddihy AR; Wong AH; Tam NW; Li S; Koromilas AE
    Oncogene; 1999 Apr; 18(17):2690-702. PubMed ID: 10348343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
    Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
    Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.